{"nct_id":"NCT03711032","title":"Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-12","start_date":"2018-12-24","start_date_type":"ACTUAL","primary_completion_date":"2025-12-31","primary_completion_date_type":"ESTIMATED","completion_date":"2034-11-20","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}